Trauma Monthly

Published by: Kowsar

Evaluation of the Effect of Glibenclamide in Patients With Diffuse Axonal Injury Due to Moderate to Severe Head Trauma

Peyman Zafardoost 1 , * , Amir Abbas Ghasemi 1 , Firooz Salehpour 1 , Chia Piroti 1 and Ehsan Ziaeii 1
Authors Information
1 Neurosurgery Department, Urmia University of Medical Sciences, Urmia, IR Iran
Article information
  • Trauma Monthly: November 01, 2016, 21 (5); e25113
  • Published Online: April 24, 2016
  • Article Type: Research Article
  • Received: November 3, 2014
  • Revised: March 13, 2015
  • Accepted: March 29, 2015
  • DOI: 10.5812/traumamon.25113

To Cite: Zafardoost P, Ghasemi A A, Salehpour F, Piroti C, Ziaeii E. Evaluation of the Effect of Glibenclamide in Patients With Diffuse Axonal Injury Due to Moderate to Severe Head Trauma, Trauma Mon. 2016 ; 21(5):e25113. doi: 10.5812/traumamon.25113.

Abstract
Copyright © 2016, Trauma Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ingebrigtsen T, Mortensen K, Romner B. The epidemiology of hospital-referred head injury in northern Norway. Neuroepidemiology. 1998; 17(3): 139-46[PubMed]
  • 2. Masson F, Thicoipe M, Aye P, Mokni T, Senjean P, Schmitt V, et al. Epidemiology of severe brain injuries: a prospective population-based study. J Trauma. 2001; 51(3): 481-9[PubMed]
  • 3. Robles JF, Navarro JEV, Maglinao MLD, Matawaran BJ, Andag-Silva AA, Mercado-Asis LB. Traumatic Injury to the Brain and Endocrine Evaluation of the Anterior Pituitary a Year After the Event (The TRIBE Study). Int J Endocrinol Metab. 2009; 2009(2): 72-81
  • 4. Syed Hassan ST, Jamaludin H, Abd Raman R, Mohd Riji H, Wan Fei K. Mental Trauma Experienced by Caregivers of patients with Diffuse Axonal Injury or Severe Traumatic Brain Injury. Trauma Mon. 2013; 18(2): 56-61[DOI][PubMed]
  • 5. Hattori N, Huang SC, Wu HM, Liao W, Glenn TC, Vespa PM, et al. Acute changes in regional cerebral (18)F-FDG kinetics in patients with traumatic brain injury. J Nucl Med. 2004; 45(5): 775-83[PubMed]
  • 6. Dusick JR, Glenn TC, Lee WN, Vespa PM, Kelly DF, Lee SM, et al. Increased pentose phosphate pathway flux after clinical traumatic brain injury: a [1,2-13C2]glucose labeling study in humans. J Cereb Blood Flow Metab. 2007; 27(9): 1593-602[DOI][PubMed]
  • 7. Bartnik BL, Hovda DA, Lee PW. Glucose metabolism after traumatic brain injury: estimation of pyruvate carboxylase and pyruvate dehydrogenase flux by mass isotopomer analysis. J Neurotrauma. 2007; 24(1): 181-94[DOI][PubMed]
  • 8. Sahuquillo J, Poca MA, Amoros S. Current aspects of pathophysiology and cell dysfunction after severe head injury. Curr Pharm Des. 2001; 7(15): 1475-503[PubMed]
  • 9. Rambiritch V, Maharaj B, Naidoo P. Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study. Clin Pharmacol. 2014; 6: 63-9[DOI][PubMed]
  • 10. Simard JM, Kilbourne M, Tsymbalyuk O, Tosun C, Caridi J, Ivanova S, et al. Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J Neurotrauma. 2009; 26(12): 2257-67[DOI][PubMed]
  • 11. Patel AD, Gerzanich V, Geng Z, Simard JM. Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. J Neuropathol Exp Neurol. 2010; 69(12): 1177-90[DOI][PubMed]
  • 12. Simard JM, Tsymbalyuk O, Ivanov A, Ivanova S, Bhatta S, Geng Z, et al. Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest. 2007; 117(8): 2105-13[DOI][PubMed]
  • 13. Simard JM, Woo SK, Norenberg MD, Tosun C, Chen Z, Ivanova S, et al. Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma. Sci Transl Med. 2010; 2(28): 28ra29[DOI][PubMed]
  • 14. Simard JM, Popovich PG, Tsymbalyuk O, Gerzanich V. Spinal cord injury with unilateral versus bilateral primary hemorrhage--effects of glibenclamide. Exp Neurol. 2012; 233(2): 829-35[DOI][PubMed]
  • 15. Simard JM, Tsymbalyuk O, Keledjian K, Ivanov A, Ivanova S, Gerzanich V. Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. Exp Neurol. 2012; 233(1): 566-74[DOI][PubMed]
  • 16. Zweckberger K, Hackenberg K, Jung CS, Hertle DN, Kiening KL, Unterberg AW, et al. Glibenclamide reduces secondary brain damage after experimental traumatic brain injury. Neuroscience. 2014; 272: 199-206[DOI][PubMed]
  • 17. Ding J, Yuan F, Guo JY, Chen H, Tian HL. Influence of glibenclamide on outcome in patients with type 2 diabetes and traumatic brain injury. Clin Neurol Neurosurg. 2013; 115(10): 2166-9[DOI][PubMed]
  • 18. Ahmed I. Glyburide in Treating Malignant Cerebral Edema. Blocking Sulfonyl Urea One (SURI-one) Receptors (P06. 239). Neurology. 2012; 78
  • 19. Kimberly WT, Battey TW, Pham L, Wu O, Yoo AJ, Furie KL, et al. Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care. 2014; 20(2): 193-201[DOI][PubMed]
  • 20. Eisenberg E, Banshal V. Glyburide (RP-1127) for traumatic brain injury (TBI). 2014;
  • 21. Sheth KN, Kimberly WT, Elm JJ, Kent TA, Yoo AJ, Thomalla G, et al. Exploratory analysis of glyburide as a novel therapy for preventing brain swelling. Neurocrit Care. 2014; 21(1): 43-51[DOI][PubMed]
  • 22. Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko L, et al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2009; 29(2): 317-30[DOI][PubMed]
  • 23. Zhou Y, Fathali N, Lekic T, Tang J, Zhang JH. Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats. Brain Res. 2009; 1270: 131-9[DOI][PubMed]
  • 24. Simard JM, Tsymbalyuk N, Tsymbalyuk O, Ivanova S, Yurovsky V, Gerzanich V. Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke. 2010; 41(3): 531-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments